Circadian rhythm disruption (CRD)-related intestinal inflammation is a significant cause of gastrointestinal disorders. Although the benefits of physical exercise have been investigated, its preventive and therapeutic roles in CRD-related intestinal inflammation remain ambiguous. Given the critical role of gut microbiota in regulating intestinal homeostasis and the inflammatory response to external stimuli, we hypothesized that gut microbiota could mediate the anti-inflammatory efficacy of physical exercise on intestinal inflammation. Initially, a two-sample bidirectional Mendelian randomization (MR) was conducted on the causality between physical exercise, intestinal inflammation, and gut microbiota. Subsequently, the preventive efficacy was evaluated in a CRD mouse model. Next, a potential anti-inflammatory mechanism was explored through transcriptomic sequencing, 16S rRNA sequencing, and fecal metabolome analysis. The results of the MR suggested alleviated intestinal inflammation from gut microbiota modulated by physical exercise. Ameliorated intestinal injury and inflammation were observed in exercising CRD mice, which was dampened by oral chenodeoxycholic acid (CDCA) administration. Then, comprehensive analysis indicated that the benefit of physical exercise may be associated with enhanced intestinal clock gene expression and the genus Prevotella. Our findings indicate the potential for the effects of physical exercise to be relevant to reduced CDCA; they also emphasize the benefits of undertaking adequate physical activity in maintaining a healthy condition within a modern lifestyle that involves various risk factors.
Background: Long-term exposure to constant light is becoming a prevalent lifestyle that is associated with irritable bowel syndrome (IBS), a chronic functional gastrointestinal disorder. Intestinal stem cells (ISCs) are an important population of cells that maintain homeostasis and function of intestinal tissues. The purpose of this study was to identify the effects of long-term constant light exposure on gastrointestinal function and the potential mechanisms of sympathetic activity on ISC. Methods: Rats housed in a 24 h constant light chamber for 4 weeks were used as the constant light exposure animal model. Hematoxylin-eosin staining and immunohistochemical examination were used to determine the pathological changes of the intestine. Propranolol (ARs inhibitor; 40 mg/kg/day), metoprolol (ADRβ1 inhibitor; 50 mg/kg/day), and Box5 (Wnt5a inhibitor; 2 μg/day) were used to examine the effect of sympathoexcitation and Wnt signaling pathway on constant light-induced gastrointestinal disorders. Results: We found that 4 weeks of constant light exposure in rats resulted in a decrease in the number of ISC and an increase in sympathetic activity. Intestinal β1-adrenoceptor expression and reactive oxygen species (ROS) were significantly increased, but Wnt5a expression decreased in the continuous light-exposed rats. Similarly, we found that administration of the β1-adrenoceptor antagonist metoprolol for 4 weeks attenuated the effects of continuous light exposure on the intestine, which was rescued by the reintroduction of Wnt5a. Conclusion: Taken together, these data indicate that sympathoexcitation is critical for disruption of ISC under constant light exposure, suggesting that targeting β1-adrenoceptor/oxidative stress/Wnt5a axis may be a potential strategy for ISC disruption induced by prolonged sustained light exposure, providing a new direction for IBS treatment.
With the development of social economy, the quality of national life has been rapidly improved, along with the accelerated aging of the population and the continued prevalence of metabolic risk factors. Cardiometabolic diseases (CMDs) have become a major disease burden for both urban and rural residents in China, and most of them are related to lifestyle changes in modern society, especially circadian rhythm disorders. Circadian rhythm regulating the activity of metabolism, such as carbohydrates, lipids, and other nutrients, is the most important pathway modulating the health. Nowadays, studies have shown that the interaction between circadian rhythmicity and gut microbiota counts for the homeostasis of metabolic health, while circadian rhythm disruption is associated with gut microbiota dysbiosis and metabolic diseases. However, there is a lack of research on the topic of gut microbiota mechanisms regulating circadian rhythm disruption leading to CMDs. With increased burden of CMDs prevention and treatment, as well as the demand of healthcare resource allocation, it prompts us to put forward a new strategy to solve this problem. This review focuses on the interactions between circadian rhythm and gut microbiota to elucidate the potential mechanisms of circadian rhythm disruption induced CMDs, providing a solid support for further prevention and treatment.